Material Generation and Molecular Evaluation of 3 Antibodies R&D Services RFQ 36C26025Q0592
Summary
AI-generated · Aug 25, 2025Generate materials and perform molecular evaluation for three antibodies as part of a research and development effort. The solicitation includes option CLIN 0001 and CLIN 0004, which may be needed depending on budget; provide pricing for these options regardless, and sign and return all amendments. The two notices are identical, with no new information or changes.
Please see attached RFQ. Option CLIN 0001 & 0004 - VA may or may not need these CLINs depending on the budget. Please provide pricing on those regardless. Sign & return all the amendments.
From Combined Synopsis/Solicitation posted on Jun 18, 2025Please see attached RFQ. Option CLIN 0001 & 0004 - VA may or may not need these CLINs depending on the budget. Please provide pricing on those regardless. Sign & return all the amendments.
From Combined Synopsis/Solicitation posted on Jul 08, 2025Notice history
2-
Combined Synopsis/Solicitation Posted Jun 18, 2025
-
Combined Synopsis/Solicitation LATEST Posted Jul 08, 2025View changes (1)
- Response Deadline: Jul 02, 2025 → Jul 23, 2025
Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA